<p><strong>Renal impairment</strong>: Dosage should be reduced in patients with creatinine clearance less than 51 ml/min.<br />
<br />
<strong>Hepatic impairment</strong>: No dosage adjustments are necessary with impairment of liver function. Hemodialysis patients should receive Meropenem after dialysis has been completed.<br />
<br />
<strong>Elderly</strong>: No dosage adjustments are necessary in elderly patients unless creatinine clearance is &lt;51 ml/min.<br />
<br />
<strong>Use in Children</strong>: Efficacy and tolerability in infants under 3 months have not been established.</p>